Regeneron Pharmaceuticals Inc - Trending symbols
Notifications
Type | Notification | Date |
---|---|---|
RSI Oversold | Oversold RSI (Relative Strength Index) | 2024-04-27 |
Trends
2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Tax Provision | 127,600 | -87,400 | 40,200 | 74,300 | 114,500 | -11,500 | 103,000 | -115,000 | -12,000 | |
Income Tax Expense | 127,600 | -87,400 | 40,200 | 74,300 | 114,500 | -11,500 | 103,000 | -115,000 | -12,000 | |
Other Stockholders Equity | -404,000 | -43,800 | -447,800 | -429,600 | -877,400 | -142,200 | -1,019,600 | 31,531,300 | 30,511,700 | |
Net Interest Income | -15,300 | -2,100 | -17,400 | -600 | -18,000 | -900 | -18,900 | 134,800 | 115,900 | |
Interest Expense | 13,600 | -500 | 13,100 | 2,200 | 15,300 | 2,100 | 17,400 | -35,400 | -18,000 | |
Net non Operating Income Other | -16,400 | -105,800 | -122,200 | -61,600 | -183,800 | 50,200 | -133,600 | 435,000 | 301,400 | |
Total Other Income Expense Net | -30,600 | -105,700 | -136,300 | -61,100 | -197,400 | 50,700 | -146,700 | 432,800 | 286,100 | |
Long-term Assets Other | 145,900 | 76,900 | 222,800 | 39,200 | 262,000 | 7,900 | 269,900 | -6,238,500 | -5,968,600 | |
Other Current Assets | 213,600 | 230,700 | 444,300 | 37,700 | 482,000 | -149,600 | 332,400 | -14,467,000 | -14,134,600 | |
Accumulated Other Comprehensive Income | 29,300 | -13,100 | 16,200 | -500 | 15,700 | -6,200 | 9,500 | -35,700 | -26,200 |
Comments
How you think about this?